JP2010515882A5 - - Google Patents

Download PDF

Info

Publication number
JP2010515882A5
JP2010515882A5 JP2009544931A JP2009544931A JP2010515882A5 JP 2010515882 A5 JP2010515882 A5 JP 2010515882A5 JP 2009544931 A JP2009544931 A JP 2009544931A JP 2009544931 A JP2009544931 A JP 2009544931A JP 2010515882 A5 JP2010515882 A5 JP 2010515882A5
Authority
JP
Japan
Prior art keywords
sleep
disorder
disorders
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009544931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010515882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/000116 external-priority patent/WO2008085888A1/en
Publication of JP2010515882A publication Critical patent/JP2010515882A/ja
Publication of JP2010515882A5 publication Critical patent/JP2010515882A5/ja
Withdrawn legal-status Critical Current

Links

JP2009544931A 2007-01-05 2008-01-04 睡眠関連障害を含むｇａｂａ関連神経学的障害を処置するためのｇタンパク質共役受容体およびその調節因子 Withdrawn JP2010515882A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87879607P 2007-01-05 2007-01-05
PCT/US2008/000116 WO2008085888A1 (en) 2007-01-05 2008-01-04 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders

Publications (2)

Publication Number Publication Date
JP2010515882A JP2010515882A (ja) 2010-05-13
JP2010515882A5 true JP2010515882A5 (enExample) 2012-03-08

Family

ID=39472025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009544931A Withdrawn JP2010515882A (ja) 2007-01-05 2008-01-04 睡眠関連障害を含むｇａｂａ関連神経学的障害を処置するためのｇタンパク質共役受容体およびその調節因子

Country Status (4)

Country Link
US (1) US20110038850A1 (enExample)
EP (1) EP2117577A1 (enExample)
JP (1) JP2010515882A (enExample)
WO (1) WO2008085888A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201692061A1 (ru) * 2014-04-15 2017-03-31 Бэлэнс Терапьютикс, Инк. Способы лечения гиперсомнии
JP6195684B2 (ja) 2014-06-03 2017-09-13 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ ピラゾール化合物及びｔ型カルシウムチャンネルブロッカーとしてのそれらの使用
CN107074822B (zh) 2014-09-15 2020-01-03 爱杜西亚药品有限公司 作为t型钙通道阻断剂的三唑化合物
LT3554490T (lt) 2016-12-16 2022-04-25 Idorsia Pharmaceuticals Ltd Farmacinis derinys, apimantis t tipo kalcio kanalo blokatorių
CA3050348A1 (en) 2017-02-06 2018-08-09 Idorsia Pharmaceuticals Ltd A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
WO2019060298A1 (en) 2017-09-19 2019-03-28 Neuroenhancement Lab, LLC METHOD AND APPARATUS FOR NEURO-ACTIVATION
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2005011612A2 (en) * 2003-07-31 2005-02-10 The Research Foundation Of State University Of New York Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
WO2005060625A2 (en) * 2003-12-11 2005-07-07 The Trustees Of Columbia University In The City Of New York Grp receptor-related methods for treating and preventing fear-related disorders
GB0328796D0 (en) * 2003-12-12 2004-01-14 Biofocus Plc Compounds which interact with the G-protein coupled receptor family
AU2006285393A1 (en) * 2005-04-27 2007-03-08 Arena Pharmaceuticals, Inc. Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Similar Documents

Publication Publication Date Title
JP6855466B2 (ja) Ｌｓｄ１阻害剤に関連するバイオマーカーおよびそれらの使用
JP6012591B2 (ja) β−ＮＧＦに対するアプタマー及びβ−ＮＧＦ介在疾患及び障害の治療におけるその使用
IL290294B2 (en) Oligonucleotides for reduction of pd-l1 expression
WO2017013061A1 (en) Biomarkers associated with lsd1 inhibitors and uses thereof
JP2013503642A5 (enExample)
AU2018397736A1 (en) Methods of cancer treatment using an ATR inhibitor
RU2017120536A (ru) Способы и композиции для модулирования экспрессии аполипопротеина (а)
CA2902186C (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
CN1419552A (zh) 2－氨基－3－烷基嘧啶酮衍生物作为GSK3β抑制剂
JP5537812B2 (ja) Ｍｃｐ−１に結合する核酸
JP2011511804A5 (enExample)
JP2005505274A5 (enExample)
JP2016513110A5 (enExample)
JP2018537093A (ja) 異所性石灰化障害を治療するための組成物およびそれを使用する方法
JP5822079B2 (ja) 疼痛治療剤
AU2022202688A1 (en) Genetic predictors of a response to treatment with CRHR1 antagonists
CA3120534A1 (en) Oligomeric nucleic acid molecule and use thereof
CN105209438A (zh) 苯氧基乙基二氢-1h-异喹啉化合物
CN1509282A (zh) 4-(苯基-哌啶-4-基亚基-甲基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑或胃肠疾病中的用途
JP4990513B2 (ja) 睡眠障害マーカーおよび睡眠障害治療剤
CN1196784C (zh) 人内皮特异受体基因的启动子及其用途
CA2634488A1 (en) Catecholamine regulated protein
JP6103637B2 (ja) 高病原性鳥インフルエンザウイルスの検出及びサーベイランス
CN1176098C (zh) 新的三螺旋形成寡核苷酸及其在抗乙肝病毒中的应用
JP2008540336A5 (enExample)